Similarly, EphA5 has been suggested to have a suppressive role in the progression of prostate cancer, highlighted by its downregulation in prostate cancer tissues and the fact that this was associated with higher Gleason scores [34]. Here, EPHA5 is linked to prostate carcinoma.